The use of AGN194310 to antagonize all RARs was as effective as the RARγ-selective antagonist against patients’ cells and the PCa cell lines, and normal prostate epithelium cells were less sensitive [211,221,222]. The gene discussed is RARG; the disease is posterior cortical atrophy.